Search clinical trials for: P2Y12 inhibitor-based SAPT after short DAPT

Total 72 results

IGLESIAS Juan Fernando
University of Bern

Not yet recruiting

P2Y12 Inhibitor-based Single Antiplatelet Therapy After a Short DAPT vs. Conventional DAPT Following PCI With a Polymer-free Drug-coated Stent for Unprotected Left Main Coronary Artery Disease (ULTRA-LM) (ULTRA-LM)

Left Main Coronary Artery Stenosis

Switzerland
Research Maatschap Cardiologen Rotterdam Zuid
Abbott Medical Devices

Recruiting

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

ST Elevated Myocardial Infarction | Dual Antiplatelet Therapy

Netherlands, Germany, Italy
Yonsei University

Recruiting

Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial

Coronary Artery Disease, Acute Coronary Syndrome

Korea, Republic of
Diagram B.V.

Completed

Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent (REDUCE)

Acute Coronary Syndrome
Zunyi Medical College

Recruiting

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

ACS - Acute Coronary Syndrome | CYP2C19 Polymorphism

China
Lepu Medical Technology (Beijing) Co., Ltd.

Not yet recruiting

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

Coronary Heart Disease

China
Shenyang Northern Hospital

Not yet recruiting

OCT or Angiography Guided De-escalation of DAPT

ST Elevation Myocardial Infarction | Dual Antiplatelet Therapy | Optical Coherence Tomography | Antiplatelet De-escalation | Neointimal Coverage

China
Gyeongsang National University Hospital

Completed

ACCEL-LOADING-ACS Study

Myocardial Reperfusion Injury | Platelet Aggregation Inhibitors | Anti-inflammatory Agent

Korea, Republic of
Seoul National University Hospital
B. Braun Korea Co., Ltd.

Completed

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial (HOST-IDEA)

Stable Angina | Unstable Angina | Non-ST Segment Elevation Myocardial Infarction

Korea, Republic of
MicroPort CRM
European Cardiovascular Research Center

Active, not recruiting

Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy (TARGET-FIRST)

Coronary Artery Disease | Myocardial Infarction, Acute

Netherlands, France, Spain, Italy, Portugal, Austria
Kyoto University, Graduate School of Medicine

Completed

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study (STOPDAPT-2)

Coronary Artery Disease

Japan
Ceric Sàrl
Boston Scientific Corporation

Completed

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization. (SENIOR)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Ischemia

France, Spain, Belgium, Switzerland, United Kingdom, Latvia, Finland, Italy, North Macedonia
China National Center for Cardiovascular Diseases

Not yet recruiting

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels (DAPT-Lp(a))

Coronary Artery Disease | Dual Antiplatelet Therapy | Elevated Lipoprotein(a) Level | Drug-Eluting Stent

China
Shenyang Northern Hospital

Not yet recruiting

OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time (OPT-GUIDNACE)

Acute Coronary Syndrome

China
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS (STOPDAPT-2 ACS)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction | Platelet Aggregation Inhibitors

Japan
University of Messina
Natasha Irrera; Gianluca Di Bella; Antonio Micari; Roberto Licordari

Recruiting

Modulation of Fibrosis-inducing Pathways in Acute Myocardial Infarction (BETA-MI)

Myocardial Infarction | Myocardial Fibrosis | Myocardial Remodeling, Ventricular

Italy
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention (MATE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Federico II University

Unknown

Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD (LONGDAPTPAD)

Peripheral Artery Disease

Italy
Abbott Medical Devices

Completed

XIENCE 28 USA Study

Coronary Artery Disease | Renal Insufficiency | Ischemic Stroke | Anemia | Thrombocytopenia | Coagulation Disorder | Hemorrhagic Stroke | Bleeding Disorder | Hematological Diseases

United States, Hong Kong, Canada, China, Spain, Belgium, Germany, Portugal, Switzerland, Taiwan, United Kingdom, Austria, Italy, Netherlands, Singapore
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea; Daiichi Sankyo Korea Co., Ltd.

Completed

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement (ADAPT-TAVR)

Aortic Valve Stenosis

Taiwan, Hong Kong, Korea, Republic of
Ajou University School of Medicine
B. Braun Korea Co., Ltd.

Unknown

ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)

Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Coronary Artery Lesions

United States
Abbott Medical Devices

Completed

XIENCE 28 Global Study

Coronary Artery Disease | Renal Insufficiency | Anemia | Thrombocytopenia | Coagulation Disorder | Stroke, Ischemic | Stroke Hemorrhagic | Bleeding Disorder | Hematological Disease

China, Spain, Belgium, Germany, Portugal, Switzerland, Hong Kong, United Kingdom, Austria, Italy, Netherlands, Singapore, Taiwan
The Medicines Company

Terminated

A Clinical Trial to Demonstrate the Efficacy of Cangrelor (PCI)

Myocardial Infarction (MI) | Acute Coronary Syndromes (ACS)

United States
China National Center for Cardiovascular Diseases

Recruiting

Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy

Anticoagulation | Coronary Endarterectomy

China
Kiyuk Chang
Seoul St. Mary's Hospital; Korea University Guro Hospital; St Vincent's Hospital and other collaborators

Recruiting

Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES (GENOSS-DAPT)

Coronary Artery Disease

Korea, Republic of
Rikke Sorensen

Recruiting

Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction (Dan-DAPT)

Myocardial Infarction

Denmark
St. Antonius Hospital
Daiichi Sankyo, Inc.

Recruiting

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? (WOEST-3)

Myocardial Infarction | Coronary Artery Disease | Stroke | Embolism | Atrial Fibrillation | Bleeding | Acute Coronary Syndrome | Atrial Flutter | NSTEMI - Non-ST Segment Elevation MI | Stent Thrombosis | STEMI - ST Elevation Myocardial Infarction

Belgium, Netherlands
Maasstad Hospital
Medtronic

Completed

Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI (DAPT-STEMI)

Myocardial Infarction | Cardiovascular Disease

Norway, Netherlands, Poland, Switzerland
Scripps Health
Medtronic

Completed

Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) (SEASIDE)

Coronary Artery Disease | Coronary Thrombosis

United States
NHS National Waiting Times Centre Board
Boston Scientific Corporation; Diagram B.V.; Venn Life Sciences; Cardialysis B.V.

Unknown

Xience Versus Synergy in Left Main PCI (IDEAL-LM)

Coronary Artery Disease
Samsung Medical Center

Recruiting

CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4 (SMART-CHOICE4)

Coronary Artery Disease

Korea, Republic of
North Texas Veterans Healthcare System

Unknown

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) (XLPADTRACE)

Peripheral Arterial Disease

United States
Federico II University
AdvicePharma Group

Active, not recruiting

Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES (PARTHENOPE)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Chronic Coronary Syndrome

Italy
Boston Scientific Corporation

Completed

EVOLVE Short DAPT Study

Coronary Artery Disease

United States, Germany, Latvia, Japan, Sweden, Brazil, Switzerland
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Marco Valgimigli

Completed

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PRODIGY)

Coronary Artery Disease

Italy
iVascular S.L.U.

Not yet recruiting

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy (ANGIODAPT)

Coronary Artery Disease
Insel Gruppe AG, University Hospital Bern

Recruiting

Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions (TAILOR-DAPT)

Coronary Artery Disease | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors

Switzerland
DR. XAVIER FREIXA

Completed

Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA) (ADALA)

Left Atrial Appendage Occlusion

Spain
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

Hormone Receptor Positive Advanced Breast Cancer

China
Memorial Sloan Kettering Cancer Center
Sanofi; Rutgers, The State University of New Jersey; University of Medicine and...

Completed

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Rectal Cancer | Colon Cancer

United States
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF (APERITIF)

Myocardial Infarction, Acute | Left Ventricular Thrombus

France
Shanghai Zhongshan Hospital

Recruiting

Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO

Stroke | Left Atrial Appendage Thrombosis | Thrombi

China
Zunyi Medical College

Recruiting

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

STEMI - ST Elevation Myocardial Infarction

China
Assistance Publique - Hôpitaux de Paris
Bayer; Action Research Group

Completed

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure (ADRIFT)

Hemorrhage | Atrial Fibrillation | Atrial Appendage

France
University of Nove de Julho
Santa Casa de Misericórdia de Porto Alegre

Completed

APT™ T3X on the COVID-19 Contamination Rate

COVID-19

Brazil
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study (STOPDAPT-3)

Acute Coronary Syndrome

Japan
LG Life Sciences

Completed

Bioequivalence of LB80380 Free Base and Maleate Salt Tablets

Hepatitis B

Korea, Republic of

Search clinical trials for: P2Y12 inhibitor-based SAPT after short DAPT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations